- ￥3900
- CUSABIO
- CN
- CSB-PA024465GA01HU
- 2025年07月13日
- ELISA,WB,IHC,IF
- Rabbit
- Human,Mouse,Rat
企业认证
相关产品推荐更多 >
PPP1CA抗体PPP1CA兔多抗抗体Serine/threonine-protein phosphatase PP1-alpha catalytic subunit antibody抗体PPP1CA Antibody, FITC conjugated抗体
￥880
QKI抗体QKI一抗抗体RNA binding protein HQK antibody抗体QKI Antibody抗体
￥3900
CDC14A抗体CDC14A一抗抗体CDC14 cell division cycle 14 homolog A antibody抗体CDC14A Antibody抗体
￥3900
MORC1抗体MORC1兔多抗抗体CT33 antibody抗体MORC1 Antibody抗体
￥440
RELA抗体RELA一抗抗体p65 antibody抗体Phospho-RELA (S468) Antibody抗体
￥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Human KAP1
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性：
/
- 标记物：
/
- 适应物种：
Human,Mouse,Rat
- 保质期：
6个月
- 抗原来源：
Homo sapiens (Human)
- 目录编号：
Q13263
- 级别：
优
- 库存：
200
- 供应商：
武汉华美生物工程有限公司
- 宿主：
Rabbit
- 应用范围：
ELISA,WB,IHC,IF
- 浓度：
>95%,Antigen Affinity Purified
- 靶点：
TRIM28
- 抗体英文名：
TRIM28 Antibody
- 抗体名：
Tripartite motif-containing protein 28 antibody
- 规格：
100μl
保存缓冲液
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20℃, Avoid freeze / thaw cycles.功能
/风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Mapping Protein Distributions on Polytene Chromosomes by Immunostaining
Reagents Ammonium sulfate (50% [w/v]) (optional, see Step 23) Antibodies, primary Affinity-purified primary antibodies are diluted in PBS containing 1% BSA. The dilutions must be adjusted for each individual primary antibody. Typical
Primer Premier: Program for Design of Degenerate Primers from a Protein Sequence
of novel genes are often faced with the problem that only a partial protein sequence is known. Several procedures are commonly used involving the reverse translation of the protein sequence into a DNA sequence. These include synthesis of a short
in 1971, it contained only seven structures (Berman, et al., 2000). Since then, the pace at which protein structures are being discovered has grown exponentially, with the PDB currently containing over 20,000 structures (PDB, 2003). Our ability
技术资料暂无技术资料 索取技术资料
